ONCOSEC MED INC's ticker is ONCS and the CUSIP is 68234L306. A total of 33 filers reported holding ONCOSEC MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $145,000 | -34.1% | 296,282 | 0.0% | 0.09% | -32.6% |
| Q2 2022 | $220,000 | -35.5% | 296,282 | 0.0% | 0.13% | -12.6% |
| Q1 2022 | $341,000 | +10.7% | 296,282 | -7.8% | 0.15% | +29.1% |
| Q4 2021 | $308,000 | -47.9% | 321,354 | +15.9% | 0.12% | -51.9% |
| Q3 2021 | $591,000 | +344.4% | 277,312 | +486.2% | 0.24% | +319.0% |
| Q2 2021 | $133,000 | -25.3% | 47,303 | +26.8% | 0.06% | -36.3% |
| Q1 2021 | $178,000 | +1.1% | 37,303 | +36.6% | 0.09% | -27.2% |
| Q4 2020 | $176,000 | +61.5% | 27,303 | -15.5% | 0.12% | +2.5% |
| Q3 2020 | $109,000 | +65.2% | 32,303 | 0.0% | 0.12% | +40.2% |
| Q2 2020 | $66,000 | +61.0% | 32,303 | 0.0% | 0.09% | +24.3% |
| Q1 2020 | $41,000 | -64.7% | 32,303 | -50.0% | 0.07% | +159.3% |
| Q4 2019 | $116,000 | +314.3% | 64,606 | +355.0% | 0.03% | +80.0% |
| Q3 2019 | $28,000 | – | 14,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SALZHAUER MICHAEL | 277,312 | $591,000 | 0.24% |
| Avidity Partners Management LP | 2,945,000 | $6,273,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 316,229 | $674,000 | 0.12% |
| J. Goldman & Co LP | 790,242 | $1,683,000 | 0.08% |
| Sandbox Financial Partners, LLC | 25,000 | $53,000 | 0.04% |
| Virtu Financial LLC | 25,166 | $54,000 | 0.01% |
| D.A. DAVIDSON & CO. | 108,500 | $231,000 | 0.00% |
| J. Goldman & Co LP | 26,300 | $56,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 361,401 | $770,000 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 49,500 | $105,000 | 0.00% |